CAS 1029364-77-9 Moxifloxacin Related Compound D - Analytical Products / Alfa Chemistry

CAT	AP1029364779
CAS	1029364-77-9
Structure
Molecular Weight	401.43

Description	United States Pharmacopeia (USP) Reference Standard
Size	15MG

1

[Cardiac Tolerance of Moxifloxacin: Clinical Experience From a Large Observational French Study in Usual Medical Practice (IMMEDIAT Study)]

P Veyssier, P Voirot, B Begaud, C Funck-Brentano

Med Mal Infect. 2006 Oct;36(10):505-12.

PMID: 17092674

1

High Doses of Levofloxacin vs Moxifloxacin Against Staphylococcal Experimental Foreign-Body Infection: The Effect of Higher MIC-related Pharmacokinetic Parameters on Efficacy

Oscar Murillo, M Eugenia Pachón, Gorane Euba, Ricard Verdaguer, Fe Tubau, Carmen Cabellos, Javier Cabo, Francesc Gudiol, Javier Ariza

J Infect. 2009 Mar;58(3):220-6.

PMID: 19217166

1

Oral Moxifloxacin vs High-Dosage Amoxicillin in the Treatment of Mild-To-Moderate, Community-Acquired, Suspected Pneumococcal Pneumonia in Adults

P Petitpretz, P Arvis, M Marel, J Moita, J Urueta, CAP5 Moxifloxacin Study Group

Chest. 2001 Jan;119(1):185-95.

PMID: 11157603

1

Reevaluation of Moxifloxacin Pharmacokinetics and Their Direct Effect on the QT Interval

Philippe Grosjean, Saïk Urien

J Clin Pharmacol. 2012 Mar;52(3):329-38.

PMID: 21415283

1

Safety and Efficacy of Sequential i.v. To p.o. Moxifloxacin Versus Conventional Combination Therapies for the Treatment of Community-Acquired Pneumonia in Patients Requiring Initial i.v. Therapy

Eric Katz, L Scott Larsen, Charles M Fogarty, Kamal Hamed, James Song, Shurjeel Choudhri

J Emerg Med. 2004 Nov;27(4):395-405.

PMID: 15498622

* Products or Services Interested: Moxifloxacin Related Compound D (1029364-77-9)
* Your question
* Name
* Email
Verification Code